Skip to content

← All news

Markets

Definium Therapeutics stock jumps 20% on Phase 3 trial results

1 source ·1 article ·Aug 12, 11:38 UTC Definium Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com Stock Market ·Aug 12, 11:38 UTC

Definium Therapeutics stock jumps 20% on Phase 3 trial results